Safety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS001)

Condition:   MERS (Middle East Respiratory Syndrome) Intervention:   Biological: ChAdOx1 MERS Sponsor:   University of Oxford Not yet recruiting

Source: ClinicalTrials.gov - January 15, 2018 Category: Research Source Type: clinical trials